GlassScriptPhysician profile
Jasmine Ghalchi
NPI 1497312045
$4,795.94
in general payments reported to CMS, 2019-2025
25 companies · $3,861 in 2025
The $3,861 reported for 2025 was more than what 98% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $47.10 · 2022: $14.29 · 2023: $162 · 2024: $712 · 2025: $3,861.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,670 · Education: $64.54.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,670.01 |
| Education | $64.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $638.83 | 2024-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $538.46 | 2023-2025 | |
| Lilly USA, LLC | $506.93 | 2023-2025 | Mounjaro, Zepbound |
| Amgen INC. | $397.26 | 2025 | Repatha, Otezla |
| Glaxosmithkline, LLC. | $350.93 | 2025 | Nucala, Arexvy, Trelegy Ellipta |
| Genzyme Corporation | $337.22 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $295.68 | 2025 | Airsupra, Breztri |
| Pfizer INC. | $257.80 | 2021-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $250.30 | 2025 | Caplyta |
| Kowa Pharmaceuticals America, INC. | $232.64 | 2025 | Zoryve |
| Verona Pharma, INC. | $225.59 | 2025 | Ohtuvayre |
| Boehringer Ingelheim Pharmaceuticals, INC. | $124.99 | 2025 | Jardiance |
| Janssen Biotech, INC. | $122.82 | 2024 | Tremfya |
| Gilead Sciences, INC. | $120.13 | 2025 | Descovy |
| Bayer Healthcare Pharmaceuticals INC. | $120.05 | 2024-2025 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $55.56 | 2023 | Cologuard Collection Kit |
| Scilex Pharmaceuticals INC. | $51.18 | 2025 | |
| Aimmune Therapeutics, INC. | $33.00 | 2025 | Zenpep |
| Electromed, INC. | $28.42 | 2025 | Smartvest |
| Paratek Pharmaceuticals, INC. | $22.69 | 2024 | Nuzyra |
| Hologic Sales and Service, LLC | $20.19 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $18.85 | 2025 | Eliquis |
| Dexcom, INC. | $17.20 | 2025 | Dexcom G6 Transmitter |
| Becton, Dickinson and Company | $14.93 | 2024 | Bd Onclarity |
| Cranial Technologies, INC | $14.29 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jasmine Ghalchi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.